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Abstract
Follicular dendritic cell sarcoma is a rare malignant neoplasm originating from follicular dendritic cells, and most of
them develop in lymph nodes of the head and neck. One third of follicular dendritic cell sarcomas occur in the
extranodal sites such as the tonsils, mesentery, and retroperitoneal organs, but those of mediastinal origin are rare.
Here, we present the case of a 16-year-old female with a large follicular dendritic cell sarcoma of posterior
mediastinal origin. The tumor was found by a chest X-ray mass examination at her high school, and she had no
subjective symptoms or significant past medical history. The tumor was diagnosed as a follicular dendritic cell
sarcoma by computed tomography-guided needle biopsy. Although the tumor compressed the mediastinal organs
and showed moderate uptake in 18-fluorodeoxyglucose positron emission tomography imaging, it was completely
resected through posterolateral incision. Histological examination revealed that spindle-shaped tumor cells formed
fascicular or storiform pattern with cellular pleomorphism. By immunohistochemical examination, the tumor cells
were found to be positive for CD21 and follicular dendritic cell antigen. Two years after surgery, the patient remains
alive with no signs of tumor recurrence.
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Background
Follicular dendritic cell sarcoma (FDCS) is a rare malig-
nant neoplasm originating from follicular dendritic cells,
and most FDCSs develop in lymph nodes of the head
and neck [1–4]. One third of FDCSs occur in the extra-
nodal sites such as the tonsils, mesentery, and retroperi-
toneal organs. However, FDCS of mediastinal origin is
rare [4]. Here, we report a case of a completely resected
FDCS originating from the posterior mediastinum.
Case presentation
A 16-year-old otherwise healthy female visited a local
hospital because of detection of a mediastinal tumor at a
school screening. Her vital signs were normal, and phys-
ical examination was completely unremarkable. The
blood test was also normal. Chest X-ray (Fig. 1a) and
chest computed tomography (CT) scan (Fig. 1b) showed
a large well-defined mass in the right posterior mediasti-
num. The mass was 8 cm in diameter and compressed
the surrounding organs (Fig. 1b). 18-fluorodeoxyglucose
positron emission tomography-CT (FDG-PET/CT)
showed a moderate uptake with a standardized uptake
value of 4.5 in the mass (Fig. 1c). A CT-guided needle
biopsy revealed spindle-shaped tumor cells. Immunohis-
tochemically, the tumor cells were positive for CD21
and fascin (data not shown). These results highly sug-
gested FDCS. The patient was referred to our hospital
for resection of the tumor because complete resection of
localized FDCS was reported to provide better survival
[2, 4]. We started surgery via a right posterolateral inci-
sion and fifth intercostal thoracotomy. Combined right
lower lobectomy of the lung was planned in the event
that the tumor had invaded the right lower lobe. The
tumor did not infiltrate into the lung or surrounding or-
gans, but highly vascularized adhesion to the right lower
lobe and esophagus was observed, which could be dis-
sected. We completely resected the tumor together with
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the para-esophageal lymph nodes adjacent to the tumor.
The operation time was 180 min, and blood loss was
575 mL.
The tumor was 80 × 65 × 40 mm in size and 110 g in
weight. It was well circumscribed, and the cut surface
was pale yellow and heterogeneous with fibrous septa
(Fig. 2a). Microscopically, spindle-shaped tumor cells
were found to form fascicles and storiform pattern.
Tumor cells had eosinophilic cytoplasm. Abundant nu-
clear pleomorphism was observed among the neoplastic
cells. Lymphocytic infiltration around the tumor cells
was also observed (Fig. 2b). Cellular atypia, necrosis, and
mitotic figures were rarely observed. Immunohistochem-
ical analyses revealed that the tumor cells were positive
for CD21 (Fig. 2c) and follicular dendritic cell antigen
(Fig. 2d), but were negative for CD68, S-100, anaplastic
lymphoma kinase, and Epstein-Barr virus-encoded small
RNA (data not shown). These findings were compatible
with FDCS. There was no evidence of the neoplasm in
the dissected para-esophageal lymph nodes.
She had a benign postoperative course and was dis-
charged 8 days after surgery. She received no adjuvant
therapy. There has been no evidence of recurrence
2 years after surgery as observed during biannual follow-
up with CT.
Discussion
FDCS is a rare low-grade malignant neoplasm arising
from the primary and secondary lymphoid follicles. It
was first described in 1986 [1], and specific immunohis-
tochemical markers such as CD21, CD23, CD35, and
fascin have been identified. Reactivity to these markers is
necessary for definitive diagnosis of FDCS [1–6]. Pos-
sible associations with Epstein-Barr virus and Castle-
man’s disease have also been reported [7]. Recent pooled
analysis has shown that FDCS generally occurs in young
to middle-aged adults, without apparent sex predilec-
tion. FDCS usually presents with painless cervical or
intra-abdominal lymphadenopathy, or as a mass in
extranodal organs such as the head and neck, liver, lung,
spleen, or retroperitoneal organs. Mediastinal origin is
uncommon, and only 20 of 334 reported cases arose in
the mediastinum [3]. According to the reports of medi-
astinal FDCS with specification of size, location, and im-
aging studies [2–18], many of the mediastinal FDCS
cases developed in the subcarinal region as in our case
[8–10, 12–15]. Usually several lymph nodes reside in the
subcarinal region, and these can be a site for develop-
ment of FDCS. The FDCS in our case most likely origi-
nated from a subcarinal lymph node although
histological evidence could not be obtained to verify this.
Some FDCSs develop in the anterior mediastinum [16–18]
or para-tracheal region [11], which are usually approxi-
mately 10 cm in diameter and range in size from 2.5 to
13.4 cm [2–18]. Imaging studies by CT show that medias-
tinal FDCS are usually well defined and with heterogeneous
soft tissue attenuation, accompanied by the areas of calcifi-
cation [8]. FDG-PET/CT shows moderate or high uptake
within the tumor, suggesting hypermetabolism of the FDCS
[8]. In many reported cases of mediastinal FDCS, complete
resection was possible and postoperative radiation therapy
was frequently performed [2–11, 13–18]. The prognosis of
mediastinal FDCS is unknown because long-term outcome
beyond 2 years has not been described in reported cases
Fig. 1 Preoperative imaging studies. Chest X-ray film showed a large para-cardiac mass in the right mediastinum (a). Contrast-enhanced
computed tomography showed a heterogeneous attenuation within the mass and a focus of coarse calcification (b). 18-fluorodeoxyglucose
(FDG) positron emission tomography/computed tomography showed moderate FDG uptake within the mass (c). Pink-colored area indicates
that the maximum standardized uptake value was 4.0 or more
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[2–18]. However, good prognosis has been reported in
complete resection cases and complete resection with post-
operative irradiation cases as a whole [4] while poor prog-
nosis of non-surgical cases (chemotherapy and / or
radiotherapy) has been reported [2, 4, 12]. However, a suc-
cessful case with multimodality treatment for mediastinal
FDCS has been reported [19].
In our case, the FDCS showed an uncommon clinical
presentation as a mid- to posterior mediastinal tumor.
We could obtain a definitive diagnosis of FDCS by CT-
guided needle biopsy in order to facilitate the decision
to perform initial operation. Dissection of the large and
hypermetabolic FDCSs of mediastinal origin seems to be
possible as shown in our case as well as in those re-
ported by Chow et al. [9] and Leipsic et al. [15]. How-
ever, Lee et al. reported that right pneumonectomy was
needed for complete resection of mediastinal FDCS [10],
and Voigt et al. [11] and Ceresoli et al. [12] reported that
complete resection of mediastinal FDCS could not be
achieved due to direct invasion into the trachea-
bronchial tree or esophagus. Therefore, resectability of
mediastinal FDCS is difficult to predict from the imaging
studies, and the appropriate approach and extent of re-
section for mediastinal FDCS should be considered dur-
ing surgery according to the intraoperative findings.
Adjuvant chemotherapy and/or radiotherapy after
complete resection are considered for FDCS with poor
prognostic features such as extensive necrosis, a mass lar-
ger than 6 cm, cytologic atypia, intraabdominal location,
and a high proliferative index that suggests a high mitotic
activity [3]. However, there is no evidence that adjuvant
treatment contributes to better survival [4]. In our case,
adjuvant therapy was not performed because the tumor
was completely resected without any surrounding lymph
Fig. 2 Pathological examinations. The cut surface of the resected tumor had a heterogeneous appearance (a). Microscopic examination
(hematoxylin-eosin staining, original magnification: ×400) revealed spindle-shaped tumor cells with pleomorphic nuclei and eosinophilic cytoplasm.
Infiltration of small lymphocytes was observed around the tumor cells (b). Immunohistochemical staining of tumor cells for CD21 (c) and FDC antigen
(d) revealed membranous and cytoplasmic positivity in the tumor cells (original magnification: ×100). The antibody used for FDC antigen was the
anti-follicular dendritic cell antibody, Clone CNA.42 (DAKO Japan Co. Ltd, Tokyo)
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node metastasis, the large tumor size (8 cm) was the only
poor prognostic factor, and the effectiveness of adjuvant
therapy was uncertain. The patient has no clinical or
radiological evidence of recurrence and metastasis 2 years
after surgery. However, she will require continued moni-
toring in order to validate the adequacy of our decision to
not perform adjuvant therapy.
Conclusions
We report a case of complete resection of a rare tumor,
mediastinal FDCS. Although the evaluation of resectabil-
ity for mediastinal FDCS is difficult and appropriate
management of it is unclear, complete resection and de-
tailed histological evaluation to determine the necessity
of adjuvant therapy are preferable.
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